Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients
K Visvanathan, T Lang, K Ryan, R Wilson, NA Skinner, AJV Thompson, SH Ahn, F Weilert, W Abbott, E Gane, D Colledge, K Li, S Locarnini, A Mansell, PA Revill
Journal of Viral Hepatitis | WILEY | Published : 2016
Awarded by NHMRC
This work was funded in part by NHMRC project grant 491017.